Cargando…
Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates
Despite rapid advances in diagnostic and treatment approaches, the overall survival rate of cancer has not been improved. Colorectal cancer (CRC) is recognized as the third leading cause of neoplasm-related deaths worldwide, in large part due to its considerable metastasis and drug resistance. For d...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Tabriz University of Medical Sciences
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726747/ https://www.ncbi.nlm.nih.gov/pubmed/31508327 http://dx.doi.org/10.15171/bi.2019.16 |